Clinical Trial Update: An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing generic ingenol mebutate gel 0.015% to Picato gel 0.015% in actinic keratosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Generic Ingenol Mebutate Gel 0.015% (ingenol mebutate)
• Picato (ingenol mebutate)

Snippet

Sponsor: Actavis Inc. | Conditions: ACTINIC KERATOSIS | Phase 3 | Status: COMPLETED | Results posted: 2020-01-14